Gu, Z., Hao, Y., Schomann, T., Ossendorp, F., ten Dijke, P., & Cruz, L. J. (2023). Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation. Journal of controlled release, 357, 531-544. https://doi.org/10.1016/j.jconrel.2023.04.011
Chicago Style (17th ed.) CitationGu, Zili, Yang Hao, Timo Schomann, Ferry Ossendorp, Peter ten Dijke, and Luis J. Cruz. "Enhancing Anti-tumor Immunity Through Liposomal Oxaliplatin and Localized Immunotherapy via STING Activation." Journal of Controlled Release 357 (2023): 531-544. https://doi.org/10.1016/j.jconrel.2023.04.011.
MLA (9th ed.) CitationGu, Zili, et al. "Enhancing Anti-tumor Immunity Through Liposomal Oxaliplatin and Localized Immunotherapy via STING Activation." Journal of Controlled Release, vol. 357, 2023, pp. 531-544, https://doi.org/10.1016/j.jconrel.2023.04.011.